Loading company…
Xintong Pharmacy, based in Xi'an, China, develops drugs for hepatitis B, liver cancer, and epilepsy, and sells traditional medicine.
Established in 2000 and based in Xi'an, China, Xintong Pharmacy provides traditional Chinese medicine, chemical drugs, and generic drugs. Its nine projects in development include CE-phosphophenytoin sodium injection, submitted for marketing authorization for generalized tonic-clonic status epilepticus. Paradefovir Mesylate Tablets for chronic hepatitis B are in Phase III trials, MB07133 injection for advanced primary liver cancer is in Phase II, and Hepunofovir fumarate tablets are in Phase I. In September 2020 the company raised more than CNY 100 million in pre-IPO funding. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in